<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>16998518</identifier>
<setSpec>1137-6627</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Pardo, F</dc:author>
<dc:author>Rotellar, F</dc:author>
<dc:author>Herrero, J I</dc:author>
<dc:author>Quiroga, J</dc:author>
<dc:description xml:lang="en">Liver transplantation is an efficient therapeutic option for terminal hepatic diseases. The principal indications of liver transplantation are hepatic cirrhosis, hepatic tumours (mainly, hepatocellular carcinoma) and acute liver failure. Over the years, the absolute contraindications for a transplant have lessened. Surgical techniques have also undergone changes. The results of liver transplant have improved so that survival one year after the transplant is close to 90% and after five years some 80% of transplanted patients continue to live.</dc:description>
<dc:type>Comparative Study</dc:type>
<dc:language>es</dc:language>
<dc:date>2006 </dc:date>
<dc:title xml:lang="es">Trasplante hep√°tico.</dc:title>
<dc:title xml:lang="en">[Liver transplantation].</dc:title>
<dc:publisher>Anales del sistema sanitario de Navarra</dc:publisher>
</metadata>
</record>
</pubmed-document>
